Idiopathic multicentric Castleman's disease: a systematic literature review.
Liu AY, Nabel CS, Finkelman BS, Ruth JR, Kurzrock R, van Rhee F, Krymskaya VP, Kelleher D, Rubenstein AH, Fajgenbaum DC.
Lancet Haematol. 2016 Apr;3(4):e163-75. doi: 10.1016/S2352-3026(16)00006-5. Epub 2016 Mar 17.
Castleman's disease, pathophysiology, advances in diagnosis and treatment.
Pertusa Mataix R, Loaiza Cabello D, García Morillo JS.
Med Clin (Barc). 2024 Mar 22;162(6):283-290. doi: 10.1016/j.medcli.2023.10.013. Epub 2023 Nov 27.
Idiopathic multicentric Castleman disease and associated autoimmune and autoinflammatory conditions: practical guidance for diagnosis.
González García A, Fernández-Martín J, Robles Marhuenda Á.
Rheumatology (Oxford). 2023 Apr 3;62(4):1426-1435. doi: 10.1093/rheumatology/keac481.
Idiopathic multicentric Castleman disease: An update in diagnosis and treatment advances.
Lang E, van Rhee F.
Blood Rev. 2024 Mar;64:101161. doi: 10.1016/j.blre.2023.101161. Epub 2023 Dec 5.
Angiofollicular lymph node hyperplasia (Castleman's disease).
McCarty MJ, Vukelja SJ, Banks PM, Weiss RB.
Cancer Treat Rev. 1995 Jul;21(4):291-310. doi: 10.1016/0305-7372(95)90034-9.
TAFRO Syndrome.
Igawa T, Sato Y.
Hematol Oncol Clin North Am. 2018 Feb;32(1):107-118. doi: 10.1016/j.hoc.2017.09.009.
Osteosclerosis in Castleman's disease.
Liu SZ, Zhou X, Wang YP, Liu Y.
QJM. 2022 Mar 22;115(3):171-172. doi: 10.1093/qjmed/hcac013.
[Castleman's disease].
Larroche C, Cacoub P, Godeau P.
Rev Med Interne. 1996;17(12):1003-13. doi: 10.1016/s0248-8663(97)80844-2.
La maladie de Castleman : aspects anatomopathologiques.
Meignin V, Parrens M.
Rev Med Interne. 2022 Dec;43(10S1):10S10-10S16. doi: 10.1016/S0248-8663(23)00020-6.
Castleman's disease.
Shahidi H, Myers JL, Kvale PA.
Mayo Clin Proc. 1995 Oct;70(10):969-77. doi: 10.4065/70.10.969.
